Recent study findings suggest that BRCA1/2, PALB2, ATM, CHEK2, and the Lynch Syndrome genes might confer reduced penetrance cancer risk among children. However, there are no adjustments to management or testing recommendations based on the level of risk (i.e., normally do not test children for conditions that primarily increase the risk of cancer in adulthood).
Use this link to learn more: https://pubmed.ncbi.nlm.nih.gov/35980168/
Reference: Kratz, et al. J Natl Cancer Inst. 2022;114(11):1523-1532. PMID: 35980168.